The microbial lipase market was valued at USD 400.6 Million in 2017 and is projected to reach USD 590.2 Million by 2023, growing at a CAGR of 6.8% from 2018, in terms of value. The objectives of this study are to define, segment, and project the size of the microbial lipase market based on application, form, source, and key regions.
This report includes the estimation of the market size for value (USD million) and volume (metric tons). Both, top-down and bottom-up approaches have been used to estimate and validate the size of the microbial lipase market and to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research (FAO, Bloomberg Businessweek, Factiva, and companies’ annual reports), and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Market Ecosystem
The various contributors involved in the value chain of microbial lipases include manufacturers, suppliers, distributors, intermediaries, and customers. The key players in the microbial lipase market include Novozymes (Denmark), DSM (Netherlands), Chr. Hansen (Denmark), Amano Enzymes (Japan), Associated British Foods (UK), DowDuPont (US), Advanced Enzymes (India), Enzyme Development Corporation (US), Aumgene Biosciences (India), Biocatalysts (UK), Meito Sangyo Co., Ltd (Japan), and Creative Enzymes (US).
Target Audience
- Raw material suppliers
- Enzyme manufacturers and suppliers
- Regulatory bodies, including government agencies and NGOs
- Commercial research & development (R&D) institutions
- Importers and exporters of microbial lipases
- Microbial lipase traders, distributors, and suppliers
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Food&farming 